Pharmaceutics I Route of Drug Administration

Pharmaceutics I Route of Drug Administration

Route of administration Is the path by which a drug, fluid, poison or other substance is brought into contact with the body

Routs of Drug administration The possible routes of drug entry into the body may be divided into two classes: – Enteral Route – Parenteral Route – Other Routes

Parenteral Route of Drug Administration Parenteral Routes: An injection is an infusion method of putting liquid into the body, usually with a hollow needle and a syringe which is pierced through the skin to a sufficient depth for the material to be forced into the body. There are several methods of injection, including: Intravenous bolus (IV) Intravenous infusion (IV inf) Intramuscular injection (IM) Subcutaneous injection (SC)

Parenteral Routes – Intravascular (IV)- placing a drug directly into the blood stream; the only systemic route with no membrane to cross. – Intramuscular (IM) - drug injected into skeletal muscle – Subcutaneous - Absorption of drugs from the subcutaneous tissues

Enteral Routes Enteral - drug placed directly in the GI tract: – sublingual (SL)- placed under the tongue – oral - swallowing (p.o.) – rectum (PR) - Absorption through the rectum Other Routes Transdermal Inhalation Intranasal Ophthalmic

Intravenous bolus (IV( Complete (100%) systemic drug absorption. Rate of bioavailability considered instantaneous. Drug is given for immediate effect. Increased chance for adverse reaction . Possible anaphylaxis

Intravenous infusion (IV inf) Complete (100%) systemic drug absorption. Rate of drug absorption controlled by infusion rate. Plasma drug levels more precisely controlled. May inject large fluid volumes. Requires skill in insertion of infusion set. Tissue damage at site of injection (infiltration, necrosis, or sterile abscess).

Intramuscular injection (IM( Rapid absorption from aqueous solution. Slow absorption from nonaqueous (oil) solutions. Larger volumes may be used compared to subcutaneous solutions. Easier to inject than intravenous injection. Irritating drugs may be very painful. Different rates of absorption depending on muscle group injected and blood flow.

Subcutaneous injection (SC( Prompt absorption from aqueous solution. Slow absorption from repository formulations. Generally, used for insulin injection. Rate of drug absorption depends on blood flow and injection volume.

Oral (PO( Absorption may vary. Generally, slower absorption rate compared to IV bolus or IM injection. Advantages: Safest and easiest route of drug administration. Variety of dosage forms available and may use immediate-release and modified-release drug products Convenient - portable, no pain, easy to take.

Oral (PO( Disadvantages Drugs may have erratic absorption, Drugs may be unstable in the gastrointestinal tract, it is destructed by gastric acid and digestive juices Drug may be metabolized by liver prior to systemic absorption "first-pass" effects. Sometimes inefficient - high dose or low solubility drugs may suffer poor availability, only part of the dose may be absorbed. unable to use in unconscious patient.

First-pass Effect The first-pass effect Is the term used for the hepatic metabolism of a pharmacological agent when it is absorbed from the gut and delivered to the liver via the portal circulation. The greater the first-pass effect, the less the agent will reach the systemic circulation when the agent is administered orally

After a drug is swallowed, it is absorbed by the digestive system and enters the hepatic portal system. It is carried through theportal vein into the liver before it reaches the rest of the body. The liver metabolizes many drugs, sometimes to such an extent that only a small amount of active drug emerges from the liver to the rest of the circulatory system. This first pass through the liver thus greatly reduces the bioavailability of the drug.

Buccal or sublingual (SL) Sublingual administration is where the dosage form is placed under the tongue Buccal administration is where the dosage form is placed between gums and inner lining of the cheek.

Rapid absorption from lipid-soluble drugs No "first-pass" effects. Some drugs may be swallowed. Not for drugs with high doses. Irritation of oral mucosa Drug taste may need to be masked.

Rectal Rectal (PR( USED FOR : 1. unconscious patients and children 2. if patient is nauseous or vomiting 3. good for drugs affecting the bowel such as laxatives

Rectal (PR( Absorption may vary from suppository. More reliable absorption from enema solution. Useful when patient cannot swallow medication Used for local and systemic effects. Absorption may be erratic. Some patient discomfort.

Transdermal Slow absorption, rate may vary. An occlusive dressing may be used to improve absorption. lower risk of side effects Transdermal delivery system (patch) is easy to use. It could achieve systemic or local effects. Used for lipid-soluble drugs with low dose and low MW.

Transdermal Disadvantages Skin irritation from the patch or drug. Permeability of skin variable with condition, anatomic site, age, and gender. Type of cream or ointment base affects drug release and absorption.

Inhalation and intranasal Rapid absorption. Total dose absorbed is variable. May be used for local or systemic effects. May stimulate cough reflex. Some drug may be swallowed.

When a drug is administered by an extravascular route of administration (eg, oral, topical, intranasal, inhalation, rectal), the drug must first be absorbed into the systemic circulation and then diffuse or be transported to the site of action before eliciting biological and therapeutic activity. The general principles and kinetics of absorption from these extravascular sites follow the same principles as oral dosing, although the physiology of the site of administration differs.

Many drugs are not administered orally because of drug instability in the gastrointestinal tract or drug degradation by the digestive enzymes in the intestine. erythropoietin and human growth hormone are administered IM, and insulin is administered SC or IM, because of the potential for degradation of these drugs in the stomach or intestine. Biotechnology products are too labile to be administered orally and are usually given parenterally.

Drug absorption after subcutaneous injection is slower than intravenous injection. Pathophysiologic conditions such as burns will increase the permeability of drugs across the skin compared with normal intact skin.

The systemic absorption of a drug is dependent on: (1) the physicochemical properties of the drug, (2) the nature of the drug product, (3) the anatomy and physiology of the drug absorption site.